161 related articles for article (PubMed ID: 20373907)
1. Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis.
Denyer J; Prince I; Dixon E; Agent P; Pryor J; Hodson M
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S29-36. PubMed ID: 20373907
[TBL] [Abstract][Full Text] [Related]
2. Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis.
Denyer J; Black A; Nikander K; Dyche T; Prince I
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S45-54. PubMed ID: 20373909
[TBL] [Abstract][Full Text] [Related]
3. The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future.
Denyer J; Dyche T
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S1-10. PubMed ID: 20373904
[TBL] [Abstract][Full Text] [Related]
4. Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA.
Nikander K; Prince I; Coughlin S; Warren S; Taylor G
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S37-43. PubMed ID: 20373908
[TBL] [Abstract][Full Text] [Related]
5. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K
J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
[TBL] [Abstract][Full Text] [Related]
6. The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation.
Geller DE; Kesser KC
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S55-9. PubMed ID: 20373910
[TBL] [Abstract][Full Text] [Related]
7. New nebulizer technology to monitor adherence and nebulizer performance in cystic fibrosis.
McCormack P; Southern KW; McNamara PS
J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):307-9. PubMed ID: 22856641
[TBL] [Abstract][Full Text] [Related]
8. Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients.
Köhler E; Sollich V; Schuster-Wonka R; Jorch G
J Aerosol Med; 2005; 18(4):386-95. PubMed ID: 16379615
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.
Hardaker LE; Hatley RH
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S11-20. PubMed ID: 20373905
[TBL] [Abstract][Full Text] [Related]
10. The Adaptive Aerosol Delivery system in a telehealth setting: patient acceptance, performance and feasibility.
Nikander K; Denyer J; Dodd M; Dyche T; Webb K; Weller P; Stableforth D
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S21-7. PubMed ID: 20373906
[TBL] [Abstract][Full Text] [Related]
11. Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) system.
Dhand R
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):iii-v. PubMed ID: 20373913
[No Abstract] [Full Text] [Related]
12. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease.
Goodman N; Morgan M; Nikander K; Hinch S; Coughlin S
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S61-70. PubMed ID: 20373911
[TBL] [Abstract][Full Text] [Related]
14. [Can mesh nebulizers improve prehospital aerosol therapy? An in vitro study on simulated prehospital emergency patients suffering from respiratory distress].
Otto M; Kropp Y; Kummer L; Thiel M; Tsagogiorgas C
Anaesthesiologie; 2022 Oct; 71(10):758-766. PubMed ID: 35976418
[TBL] [Abstract][Full Text] [Related]
15. The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis.
van Velzen AJ; Uges JW; Le Brun PP; Shahbabai P; Touw DJ; Heijerman HG
J Cyst Fibros; 2015 Nov; 14(6):748-54. PubMed ID: 25636858
[TBL] [Abstract][Full Text] [Related]
16. A randomised controlled trial of breathing modes for adaptive aerosol delivery in children with cystic fibrosis.
McCormack P; McNamara PS; Southern KW
J Cyst Fibros; 2011 Sep; 10(5):343-9. PubMed ID: 21620782
[TBL] [Abstract][Full Text] [Related]
17. Effect of Aerosol Devices and Administration Techniques on Drug Delivery in a Simulated Spontaneously Breathing Pediatric Tracheostomy Model.
Alhamad BR; Fink JB; Harwood RJ; Sheard MM; Ari A
Respir Care; 2015 Jul; 60(7):1026-32. PubMed ID: 25737572
[TBL] [Abstract][Full Text] [Related]
18. Performance Comparisons of Jet and Mesh Nebulizers Using Different Interfaces in Simulated Spontaneously Breathing Adults and Children.
Ari A; de Andrade AD; Sheard M; AlHamad B; Fink JB
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):281-9. PubMed ID: 25493535
[TBL] [Abstract][Full Text] [Related]
19. Aerosol delivery during spontaneous breathing with different types of nebulizers- in vitro/ex vivo models evaluation.
Lin HL; Fang TP; Cho HS; Wan GH; Hsieh MJ; Fink JB
Pulm Pharmacol Ther; 2018 Feb; 48():225-231. PubMed ID: 29277689
[TBL] [Abstract][Full Text] [Related]
20. Quantifying Aerosol Delivery in Simulated Spontaneously Breathing Patients With Tracheostomy Using Different Humidification Systems With or Without Exhaled Humidity.
Ari A; Harwood R; Sheard M; Alquaimi MM; Alhamad B; Fink JB
Respir Care; 2016 May; 61(5):600-6. PubMed ID: 26908921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
